News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Arnold Susan Elizabeth
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2021 |
4
| Arnold Susan Elizabeth (SVP, Technical Operations) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Granted 2,559 shares
@ $2.01, valued at
$5.1k
|
|
| 09/03/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/14/2021 |
4
| Arnold Susan Elizabeth (VP, Preclinical and Chem) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Granted 4,519 shares
@ $1.74, valued at
$7.9k
|
|
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Arnold Susan Elizabeth (VP, Preclinical and Chem) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Granted 36,000 options to buy
@ $4.31, valued at
$155.2k
|
|
| 11/23/2020 |
4
| Arnold Susan Elizabeth (VP, Preclinical and Chem) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Granted 4,832 shares
@ $3, valued at
$14.5k
|
|
| 10/05/2020 |
4
| Arnold Susan Elizabeth (VP, Preclinical and Chem) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Exercised 5,423 options to buy
@ $1.15, valued at
$6.2k
Exercised 5,423 options to buy
@ $1.15, valued at
$6.2k
|
|
| 02/14/2020 |
4
| Arnold Susan Elizabeth (VP, Preclinical and Chem) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Granted 55,000 options to buy
@ $5.19, valued at
$285.5k
|
|
| 03/01/2019 |
4
| Arnold Susan Elizabeth (VP, Preclinical and Chem.) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Granted 45,000 options to buy
@ $3.15, valued at
$141.8k
|
|
| 10/24/2018 |
4
| Arnold Susan Elizabeth (VP, Preclinical and Chem.) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Converted 2,306 shares
@ $0
Exercised 103 options to buy
@ $0.12, valued at
$12.4
Exercised 103 preferred shares
@ $0.12, valued at
$12.4
Converted 2,306 preferred shares
@ $0 |
|
| 10/17/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|